Silver Book

Silver Book Fact

Mitral regurgitation patients who did not undergo surgery saw an increased use of medical therapies from 12% to 47% over 4.5 years.

Goel S, Bajaj N, Agaarwall B, Gupta S, et al. Prevalence and Outcomes of Unoperated Patients with Severe Symptomatic Mitral Regurgitation and Heart Failure. J Am Coll Cardiol. 2014; 63(2). http://www.onlinejacc.org/content/63/2/185

Reference

Title
Prevalence and Outcomes of Unoperated Patients with Severe Symptomatic Mitral Regurgitation and Heart Failure
Publication
J Am Coll Cardiol
Publication Date
2014
Authors
Goel S, Bajaj N, Agaarwall B, Gupta S, et al.
Volume & Issue
Volume 63, Issue 2
URL
Read Full Resource

Categories

  • Cost of Disease
  • Human Burden

Publications

Silver Book: Valve Disease Volume

 https://www.silverbook.org/wp-content/uploads/2018/02/SB-Vol-TN.jpg Thumbnail

Connected Facts

Aortic Stenosis

Fact image
Aortic stenosis often undertreated
Cost of Disease

Mitral Valve Disease

Fact image
Human Burden

Mitral Valve Disease

Fact image
Patients with severe MR who don’t have surgery have mortality rates of 20% after 1-year and 50% after 5-years
Human Burden

Aortic Stenosis

Fact image
Medicare patients with sSAS have an average lifespan of 1.8 years without repair or replacement
Human Burden

Related Facts

  • 2.6% of all Americans have suffered a heart attack at some point in their lives.  
  • An estimated 73 million adult Americans have high blood pressure.  
  • Most common causes of death after AFib diagnosis
    Within the first 4 months of diagnosis of atrial fibrillation, the most common cause of cardiovascular deaths are coronary artery disease (22%), heart failure (14%), and ischemic stroke (10%). After…  
  • The number of ambulatory care visits to physician offices, hospital outpatient departments, and emergency departments for hypertension was 45.3 million for 2001-2002.  
  • Survival rates for patients with sSAS without repair or replacement